GlassScriptPhysician profile
Adrienne Schupbach
NPI 1740415777
$7,309.38
in general payments reported to CMS, 2019-2025
37 companies · $628 in 2025
The $628 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,364 · 2020: $559 · 2021: $1,425 · 2022: $1,199 · 2023: $1,110 · 2024: $1,024 · 2025: $628.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,391 · Education: $371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,391.17 |
| Education | $371.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,066.20 | 2019-2025 | Rinvoq, Skyrizi |
| Smith+Nephew, INC. | $1,029.35 | 2019-2022 | |
| Janssen Biotech, INC. | $826.10 | 2019-2025 | Tremfya, Simponi Aria, Simponi |
| Novartis Pharmaceuticals Corporation | $621.65 | 2019-2023 | |
| Lilly USA, LLC | $480.09 | 2019-2024 | Taltz, Olumiant, Ebglyss |
| Sun Pharmaceutical Industries INC. | $434.80 | 2019-2025 | Ilumya |
| Genzyme Corporation | $340.84 | 2019-2025 | |
| Pfizer INC. | $302.20 | 2019-2024 | |
| Ucb, INC. | $258.28 | 2019-2024 | Bimzelx, Cimzia |
| Regeneron Healthcare Solutions, INC. | $257.94 | 2019-2025 | Dupixent, Libtayo |
| Amgen INC. | $243.95 | 2019-2024 | Otezla |
| Leo Pharma INC. | $208.60 | 2021-2025 | Adbry |
| E.R. Squibb & Sons, L.L.C. | $161.83 | 2022-2024 | Sotyktu |
| Incyte Corporation | $151.98 | 2021-2025 | Opzelura |
| Organogenesis INC. | $133.78 | 2023-2025 | Novachor, Via Matrix, Cygnus Dual |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adrienne Schupbach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.